During the past decade, Family Allergy and Asthma Institute conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Family Allergy and Asthma Institute" are "Rhinitis, Seasonal, Allergic" (1 trials) and "Seasonal Allergic Rhinitis" (1 trials). Many other conditions were trialed in "Family Allergy and Asthma Institute" in a lesser frequency.

Most popular intervention types in "Family Allergy and Asthma Institute" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Atropine 0.24 mg" (1 trials), "PSE 120 mg, CM 8 mg" (1 trials), "PSE 120 mg, CM 8 mg, Atr 0.12 mg" (1 trials), "PSE 120 mg, CM 8 mg, Atr 0.24 mg" (1 trials) and "PSE 120 mg, CM 8 mg, Atr 0.36 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Family Allergy and Asthma Institute" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Family Allergy and Asthma Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Family Allergy and Asthma Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Family Allergy and Asthma Institute, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".